Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism
- 1 July 1985
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 38 (1) , 71-76
- https://doi.org/10.1038/clpt.1985.137
Abstract
After the oral administration of 160 mg pseudoracemic verapamil (80 mg d isomer and 80 mg l isomer), the prolongation of the PR interval was assessed in relation to d- and l-verapamil plasma concentrations. Concentration-effect curves were analyzed with the sigmoidal Emax model. Because of stereoselective 1st-pass metabolism, the mean plasma d- to l-verapamil concentration ratio of 4.5 .+-. 1.2 was substantially greater than that of 2.1 .+-. 0.3 after i.v. dosing. Compared with the concentration after i.v. injection, the total verapamil concentration after oral dosing consisted of a substantially smaller proportion of the more potent l-isomer. These differences in isomer composition of the total verapamil plasma concentration as a result of the route of administration explain the diminished negative dromotropic potency of racemic verapamil after oral dosing. The concentration required to reach 50% of the maximum effect (EC50) for total verapamil concentration was 129.0 .+-. 22.9 ng/ml, which was more than 3 times higher than that after i.v. injection. To assess the relative contributions of the d- and l-isomers to overall dromotropic potency, changes in the PR interval were measured after separate oral dosing with 250 mg d-verapamil and 100 mg l-verapamil. The EC50 showed an 11-fold difference between the l- (36.9 .+-. 14.7 ng/ml) and d- (363.1 .+-. 64.2 ng/ml) isomers. The EC50 for the l-isomer concentration after oral pseudoracemic verapamil (20.2 .+-. 6.3 ng/ml) did not differ significantly from that after l-verapamil alone (36.9 .+-. 14.7 ng/ml). The l-isomer determines the negative dromotropic effects of verapamil and that the d-isomer is of minor importance.This publication has 16 references indexed in Scilit:
- Differential effect of verapamil isomers on sinus node and AV junctional regionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1983
- Comparison of intravenous and oral verapamil dosingClinical Pharmacology & Therapeutics, 1982
- The Pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral dosesClinical Pharmacology & Therapeutics, 1982
- Treatment of Supraventricular Arrhythmias with Intravenous and Oral VerapamilChest, 1981
- Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or FlutterAnnals of Internal Medicine, 1981
- Intravenous Verapamil for Termination of Re-Entrant Supraventricular TachycardiasAnnals of Internal Medicine, 1980
- Effects on atrioventricular conduction and blood flow of enantiomers of verapamil and of tetrodotoxin injected into the posterior and the anterior septal artery of the atrioventricular node preparation of the dogNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dogCardiovascular Research, 1978
- Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamilNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- Reversible inhibition of potassium contractures by optical isomers of verapamil and D 600 on slow muscle fibres of the frogNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976